Please login to the form below

Not currently logged in
Email:
Password:

Konstantin Linnik to head IP strategy at Idea Pharma

Former senior corporate counsel at Pfizer joins clinical stage strategy consultancy as general counsel and principal IP strategist

Konstantin Linnik - Idea PharmaIdea Pharma has appointed former senior corporate counsel at Pfizer Konstantin Linnik as its general counsel and principal intellectual property (IP) strategist.

Idea, which specialises in advising a company's strategy at the phase II stage of development, said Linnink will lead IP inputs into whole product design, giving insight into the potential opportunities for early phase assets and advising on how to improve developmental products.

The appointment is also expected to expand Idea's portfolio of clients to medium-sized pharma companies, and also give the company a base in Boston, US.

Linnik, who will join from Boston law firm Nutter McClennen and Fish LLP, said Idea's focus on distinct elements such as IP during early phase development influenced his decision to join the company.

He said: “A small change in product concept, that produces a better medicine, one with even six months more protection, can make billions of dollars difference over the lifecycle.”

Mike Rea, CEO of Idea, said: “The fantastic thing about Konstantin is that he gets it - that the role of invention isn't over when someone comes up with a pathway and a molecule.”

20th December 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GK Strategy

GK is award-winning independent communications agency specialising in delivering impactful strategies for clients across the healthcare market....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics